Is 'More' always 'Better'? Moving towards Optimal Utilization of High Dependency Intensive Care Beds by Selecting the Right Patients for Admission
In Australasia and other modern industrialized countries there is an increasing public demand for quality health care 1 and an increased expectation that individuals should have universal access to intensive care 2 . An ageing population is expected to further increase the demand and cost of health care services 3, 4 . Recent international projections suggest that the future requirements for intensive care will increase significantly 5 . The high cost of health care has become a matter of international concern. Governments and health funding institutions are systematically seeking to reduce health care costs. The cost of providing care in the intensive care unit (ICU), approximately A$2670/day 6 , is several times that of general ward care and is likely to increase further as it must keep pace with advancing technology. It therefore becomes important to demonstrate that intensive care is utilized in a way that maximizes health gains and that the high cost of providing intensive care is justified. The concept of the high dependency unit (HDU) is to provide a high care environment that provides some of the facilities of an ICU, but does not have the capability of providing advanced life-support, particularly ventilation 7 , and can be provided at a cost somewhere between that of a ward and an ICU bed. However a fundamental principle of the application of any health technology is knowing how best to deliver that technology and it is in this context that the paper by McIlroy and colleagues 8 is important.
Acknowledging resource limitations and the necessity to triage within their institution, McIlroy and colleagues have taken the opportunity to address a fundamental question about high dependency unit (HDU) utilization-do postoperative high-risk patients not admitted to the HDU suffer harm attributable to the lack of HDU care, or put another way, does HDU care improve patient outcome in this group of patients? The authors used length of stay in hospital as their primary outcome, but also recorded significant morbidity and mortality. While performing a randomized, controlled trial would have provided more definitive answers, randomizing high-risk postoperative patients to HDU or no HDU admission would not have been considered ethical, given the widely held belief that HDU does benefit high-risk patients. Therefore the authors are to be congratulated on their use of alternative methodology to try to provide best possible answers. Previous papers supporting the use of HDUs have relied on invoking common sense and drawing inferences from uncontrolled data to support the use of HDU for the management of high-risk patients 7 . There are several potential weaknesses of the methodology used by McIlroy and colleagues, but they are well discussed by the authors, and the end result is a realistic presentation of controlled data that describes their current use of their HDU facilities in high-risk postoperative patients 8 .
At first glance, the results appear surprising. Despite similar baseline demographic variables as well as morbidity and mortality prediction scores, the patients admitted to HDU had a significantly longer hospital length of stay. The methodology used by the authors does not allow exclusion of selection bias by the admitting HDU team, and the authors propose that it is this subtle selection bias that resulted in a sicker group of patients being recognized and subsequently admitted to the HDU, hence the longer length of stay. It is possible that this is the true explanation, but other explanations with interesting implications are also plausible.
Is it possible that more is in fact not always better and that HDU care, when compared with ward care, is actually harmful to some patients? If we choose to believe that the objective indicators of morbidity and mortality such as the ASA score, POSSUM 8 score, and other baseline demographics are telling us the truth and that the two groups are in fact similar at baseline, then we must conclude that the HDU is delaying discharge for the majority of patients. All-cause morbidity is also higher in the group admitted to HDU, although not significantly so. Is there a plausible explanation for the finding that HDU is detrimental to postoperative recovery?
The stratification of patients by ASA status provides an interesting insight into the utilization characteristics and outcomes of the postoperative patients in this study. The ASA score subjectively categorizes patients by preoperative physical fitness and is associated with outcome 9 . The majority of patients admitted to the HDU in this study were characterized as ASA physical status I, II or III and clearly had a prolonged hospital stay compared to those refused HDU admission. However, in the case of patients categorized as ASA IV, the opposite occurred and the length of hospital stay was reduced in those who were admitted to HDU. Although the numbers are small, this suggests that it was only the least physically fit ASA IV patients who benefited from HDU care, while the more physically fit seemed to do worse in HDU.
This observation could be explained by considering the potential beneficial effects and side-effects of HDU care. In the HDU, the common use of invasive monitoring, aggressive use of interventions such as analgesia, fluid resuscitation or inotropes to maintain perfect physiological parameters might reasonably be expected to improve the outcome of an unstable patient postoperatively. However, the side-effects of these interventions are well known, and to them must be added other potential risks of being in an HDU environment-immobilization to facilitate monitoring, increased risk of hypostatic pneumonia or thrombo-embolic phenomena, nosocomial infections or even excess patient fatigue. Some or all of these factors could potentially slow recovery. While these side-effects may well be outweighed by the benefits derived from HDU interventions in unstable patients, in relatively well patients the side-effects must be borne, without any benefit being derived.
Thus it is plausible that the patients categorized as ASA I-III in this study, were not unstable enough to benefit from HDU care and recovery was slowed, whereas the ASA IV patients were unstable enough to benefit from the more aggressive care and this shortened their recovery and length of stay. Overall, the POSSUM data suggests that the patients referred to the HDU were reasonably unstable, with an expected mortality of about 11 to 15%, but POSSUM is well known to overestimate mortality and morbidity, especially at the low end. The reported mortality of the entire cohort, including the ASA IV patients, was only 2%, and it is therefore possible that the overall results describe a majority of patients in the cohort who were really too well to benefit from HDU admission. A recent study of ICU triage in a similarly resource-limited setting, using similar methodology, showed similar findings 10 . Patients in this study were stratified by severity of illness using the mortality probability model II (MPMII o ). Comparing the difference between observed and expected mortality between patients admitted and refused ICU admission, it was shown that only those patients with moderate to severe severity of illness benefited from ICU admission. Those patients with a lower severity of illness suffered excess mortality after admission to ICU, compared with their refused counterparts. This finding may again be interpreted to demonstrate that patients who can derive little benefit from an ICU environment because they are not ill enough, suffer only the inherent side-effects.
Thus an important question needs to be asked. Is it possible that less ill subgroups of patients admitted to HDU and/or ICU are at risk of net harm? These studies are not proof that HDU or ICU admission causes harm to some patients, but the possibility that the finding is a real one has important implications. Correctly identifying patients who will not benefit or may be harmed by ICU or HDU admission would allow us to both improve outcomes and reduce costs, an ideal utilization advance. Recognising that a group of patients may exist for whom HDU and ICU will not be of benefit and who may be incorrectly allocated to a less beneficial and a more costly path of care poses a challenge. It can be seen from the ASA stratification data that, in contrast to ASA I to III patients, a larger proportion of ASA IV patients referred for admission were in fact admitted to HDU. This suggests that the admitting team did recognise an increasing need for these patients to be treated in HDU. The ICU study referred to earlier likewise showed that patients who were more ill were also more likely to be admitted. This appears to imply that there is some intuitive recognition of the types of patients who will benefit most, but many patients who do not seem to benefit are still admitted. While intensivists tend to be well aware of triage on the basis of severe illness, refusing those patients too ill to benefit, it is perhaps time for more attention to be paid to those patients who are too well to benefit, especially if admission may result in harm.
As with much innovative research, the data from this study leads us to ask more questions than it answers. Is the data presented in this study telling us that the ICU admitting team in the hospital described is capable of identifying subtle signs of illness, not obvious in the scoring systems used, and allocating them appropriately to HDU? The authors provide reasonable justification to support their belief that the answer to this question is yes. Alternatively, are many patients referred to the HDU being unnecessarily exposed to a high dependency environment eDitorial and not deriving any benefit? We have argued that this possibility cannot be excluded. The data from this study alone does not allow any firm conclusion. More studies using similar methodology, but involving many more patients and several centres will be needed before the true answer to these questions becomes apparent.
In a world of increasing cost-containment and accountability, it will become increasingly necessary to justify the utilization and cost of expensive environments such as HDU and ICU. It is somewhat disconcerting to note that the first study of significant size to demonstrate that ICU admission has a positive effect on outcome with some attempt to control confounding factors such as severity of illness was published only recently 11 . The HDU is proposed as an alternative, cheaper high care environment to ICU for those not requiring all the resources of ICU care; nevertheless HDU care is still expensive and its positive impact on outcome still needs to be convincingly demonstrated. Importantly, study design should attempt to identify those patients who will benefit most. The conduct and publication of this paper by McIlroy and co-workers is a clear indication of awareness of this need, and further similar studies that quantify the potential benefits of ICU and HDU should be encouraged.
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